These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22683647)

  • 21. Recent developments in lactose blend formulations for carrier-based dry powder inhalation.
    Hebbink GA; Jaspers M; Peters HJW; Dickhoff BHJ
    Adv Drug Deliv Rev; 2022 Oct; 189():114527. PubMed ID: 36070848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-line quantification of drug and excipients in cohesive powder blends by near infrared spectroscopy.
    Liew CV; Karande AD; Heng PW
    Int J Pharm; 2010 Feb; 386(1-2):138-48. PubMed ID: 19922776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microscale granulation in a fluid bed powder processor using electrostatic atomisation.
    Kivikero N; Murtomaa M; Ingelbeen B; Antikainen O; Räsänen E; Mannermaa JP; Juppo AM
    Eur J Pharm Biopharm; 2009 Jan; 71(1):130-7. PubMed ID: 18703138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process.
    De Beer TR; Bodson C; Dejaegher B; Walczak B; Vercruysse P; Burggraeve A; Lemos A; Delattre L; Heyden YV; Remon JP; Vervaet C; Baeyens WR
    J Pharm Biomed Anal; 2008 Nov; 48(3):772-9. PubMed ID: 18799281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance.
    Jones MD; Santo JG; Yakub B; Dennison M; Master H; Buckton G
    Int J Pharm; 2010 May; 391(1-2):137-47. PubMed ID: 20211715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Process characterization of powder blending by near-infrared spectroscopy: blend end-points and beyond.
    Shi Z; Cogdill RP; Short SM; Anderson CA
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):738-45. PubMed ID: 18486399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of electrostatic charging on pharmaceutical powder blending homogeneity.
    Pu Y; Mazumder M; Cooney C
    J Pharm Sci; 2009 Jul; 98(7):2412-21. PubMed ID: 18855912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C; Price R; Shur J; Kaerger JS; Edge S
    Int J Pharm; 2010 May; 390(2):134-41. PubMed ID: 20100552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
    Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S; Schoenbrodt T; Weiler C; Friess W
    Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.
    Shur J; Saluja B; Lee S; Tibbatts J; Price R
    AAPS J; 2015 Sep; 17(5):1105-16. PubMed ID: 25956383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The consequences of granulate heterogeneity towards breakage and attrition upon fluid-bed drying.
    Nieuwmeyer F; van der Voort Maarschalk K; Vromans H
    Eur J Pharm Biopharm; 2008 Sep; 70(1):402-8. PubMed ID: 18440211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
    Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
    Int J Pharm; 2012 Jul; 430(1-2):26-33. PubMed ID: 22449413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
    Depreter F; Amighi K
    Eur J Pharm Biopharm; 2010 Nov; 76(3):454-63. PubMed ID: 20797437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.